现在位置 >首页 > 时讯速递
[Lancet发表论文]:奥密克戎流行期间的妊娠结局与疫苗有效性已关闭评论
ARTICLES|ONLINE FIRST Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study Jose Villar, Constanza P Soto Conti, Robert B Gunier, et al Lancet Published:January 17, 2023 DOI:https://doi.org/10.1016/S0140-6736(22)02467-9 Summary Background In 2021, we showed an increased risk associated with COVID-19 in pregnancy. Since then, the SARS-CoV-2 virus has un...
阅读全文
[NEJM发表论文]:阿司匹林或低分子肝素进行骨折后血栓预防已关闭评论
ORIGINAL ARTICLE Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture Major Extremity Trauma Research Consortium (METRC) N Engl J Med 2023; 388:203-213DOI: 10.1056/NEJMoa2205973 Abstract BACKGROUND Clinical guidelines recommend low-molecular-weight heparin for thromboprophylaxis in patients with fractures, but trials of its effectiveness as compared with aspirin are lacking. METHODS In this pragmatic, multicenter, randomi...
阅读全文
[JAMA发表论文]:氯伏沙明与安慰剂对轻中度新冠病毒感染门诊患者病情持续恢复时间的影响已关闭评论
Original Investigation  January 12, 2023 Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial Matthew W. McCarthy, Susanna Naggie, David R. Boulware, et al JAMA. Published online January 12, 2023. doi:10.1001/jama.2022.24100 Key Points Question  Does 50 mg of fluvoxamine twice daily for 10 days, compared with placebo, shorten symptom duration amo...
阅读全文
[Nature新闻]:ChatGPT被列为研究论文作者:很多科学家对此表示反对已关闭评论
NEWS 18 January 2023 ChatGPT listed as author on research papers: many scientists disapprove At least four articles credit the AI tool as a co-author, as publishers scramble to regulate its use. Chris Stokel-Walker Nature 613, 620-621 (2023) doi: https://doi.org/10.1038/d41586-023-00107-z The artificial-intelligence chatbot ChatGPT is disrupting many industries, including academia.Credit: Iryna Imago/Shutterstock The artificial-intelligence (AI) ...
阅读全文
[JAMA发表论文]:大型医学中心住院患者抽血的时间已关闭评论
Research Letter  January 17, 2023 Timing of Blood Draws Among Patients Hospitalized in a Large Academic Medical Center César Caraballo, Shiwani Mahajan, Karthik Murugiah, et al JAMA. 2023;329(3):255-257. doi:10.1001/jama.2022.21509 Sleep is a key element of patient care and experience, and its deprivation among hospitalized patients is an important stressor that increases their risk of adverse events during and after hospitalization.1-3&...
阅读全文
[JAMA发表论文]:早期高流量氧疗与标准氧疗对急性低氧性呼吸功能衰竭患儿住院日的影响已关闭评论
Original Investigation  Caring for the Critically Ill Patient January 17, 2023 Effect of Early High-Flow Nasal Oxygen vs Standard Oxygen Therapy on Length of Hospital Stay in Hospitalized Children With Acute Hypoxemic Respiratory Failure: The PARIS-2 Randomized Clinical Trial Donna Franklin, Franz E. Babl, Shane George, et al JAMA. 2023;329(3):224-234. doi:10.1001/jama.2022.21805 Key Points Question  Does the early use of nasa...
阅读全文
[JAMA发表论文]:出院后使用托拉塞米与呋塞米对心衰患者全因病死率的影响已关闭评论
Original Investigation  January 17, 2023 Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial Robert J. Mentz, Kevin J. Anstrom, Eric L. Eisenstein, et al JAMA. 2023;329(3):214-223. doi:10.1001/jama.2022.23924 Key Points Question  Does torsemide reduce all-cause mortality compared with furosemide in patients with heart fail...
阅读全文
[NEJM发表论文]:长效干扰素Lamda早期治疗新冠病毒感染已关闭评论
ORIGINAL ARTICLE Early Treatment with Pegylated Interferon Lambda for Covid-19 Gilmar Reis, Eduardo A.S. Moreira Silva, Daniela C. Medeiros Silva, et al N Engl J Med 2023; 388:518-528DOI: 10.1056/NEJMoa2209760 Abstract BACKGROUND The efficacy of a single dose of pegylated interferon lambda in preventing clinical events among outpatients with acute symptomatic coronavirus disease 2019 (Covid-19) is unclear. METHODS We conducted a randomized, control...
阅读全文
[Lancet Respir Med发表论文]:吡非尼酮治疗类风湿关节炎相关肺间质病的安全性、耐受性与疗效已关闭评论
ARTICLES| VOLUME 11, ISSUE 1, P87-96, JANUARY 01, 2023 Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study Joshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al. Lancet Respir Med 2023; 11: 87-96 Published:September 05, 2022 DOI:https://doi.org/10.1016/S2213-2600(22)00260-0 Summary Background Inters...
阅读全文
[BMJ发表论文]:新冠病毒感染轻症一年后的长新冠预后已关闭评论
Research Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study Barak Mizrahi, Tamar Sudry, Natalie Flaks-Manov, et al BMJ 2023; 380 doi: https://doi.org/10.1136/bmj-2022-072529 (Published 11 January 2023)Cite this as: BMJ 2023;380:e072529 Abstract Objectives To determine the clinical sequelae of long covid for a year after infection in patients with mild disease and to evaluate its association with age, sex, SARS-CoV-...
阅读全文
×
腾讯微博